Cell Culture Media Market Trends

Growth Drivers

• Increasing Advancements in Human Genetics and Genome Research – Rising attempts to understand the structure and function of genetic sequences and of downstream biological products that determine the genetic bases of many diseases are leading toward the surging exploration in the field of genomics. The potential of the human genetics and the genomics industry is anticipated by the direct economy generated by this industry in America in 2020 which exceeded USD 108 billion. Hence, the growing advancements in the field of genetic engineering as well as the increasing use of cell medium for tissue preservation and modification of cells are expected to boost the cell culture media market over the forecast period.
• Rising Research & Development (R&D) Spending in the Biopharmaceutical Sector – The surge in the demand for vaccines, blood, and blood components, allergenic to treat allergies, body cells and tissues, living cells used in cell therapies, gene therapies, and recombinant therapeutic proteins is responsible for the increasing R&D by the biopharma companies. For instance, as per findings, the biopharmaceutical industry in the U.S. invested around USD 102 billion into R&D in 2018. This surge in investments is also anticipated to propel the market expansion of cell culture media in the upcoming years as many of these products are designed to support the growth and maintenance of a variety of human cells and cell lines which enables various drug development.
• Growing Number of Regenerative Medicine Companies - the rising prevalence of chronic diseases as well as the increasing number of organ transplantation cases, and advancements in new product launches are all attributed to the growth of the regenerative medicine facilities. As of 2023, there are over 1,457 companies of regenerative medicine worldwide. This robust expansion is anticipated to propel market growth.
• Increasing Investment in Healthcare Sector with Rising Healthcare Expenditure - The elevated burden of chronic diseases along with the surge in the number of surgical procedures is leading to rising investment in the healthcare sector across the globe.  According to the data provided by the sources, when it comes to health care the United States is the highest-spending country worldwide. The overall health expenditure in the U.S. rose beyond USD 4 trillion in 2020. Moreover, expenditure as a percentage of GDP is anticipated to rise by about 20% by the year 2028.

Challenges

• Challenges related to reproducibility, contamination, viability, and the transition to automation – prevail despite the adoption of different approaches and techniques and this is anticipated to hamper the market growth over the forecast period. The market is facing difficulty to grow viable cells in the desired quantity to obtain reproducible results, owing to which the growth of the market is restricted. Moreover, as isolated cells are highly vulnerable to contamination, their preventive handling and processing is a major threat.
• Stringent regulatory frameworks involved in process manufacturing
• Dearth of skilled professional